Guests: FREE
Members: FREE
Partners: FREE
On-Demand Webinar
MedAxiom Members and Partners:
Contact Academy Support to request access or reset your password
MedAxiom Non-Members and Non-Partners:
Sign up as a guest
Take an exclusive look at emerging cardiovascular innovation from the 2025 HeartX cohort, MedAxiom and HealthTech Arkansas’s accelerator focused on supporting early-stage companies advancing cardiovascular care.
This session featured:
CathVision highlighted its ECGenius system, which delivered high-fidelity, noise-cancelling cardiac signals to support ablation decisions. Its technology also provided real-time tissue feedback during pulsed field ablation and identified focal AFib drivers to help guide more precise interventions.
FibriCheck showcased its FDA-cleared platform for remote AFib detection and monitoring, using smartphone-based assessments and AI-powered reporting to support clinical workflows, informed decision-making, and expanded access to at-home rhythm monitoring.
Lars Grieten, CEO & Co-Founder, FibriCheck
Michael Iversen, Commercial Strategy, CathVision
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.